Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior

Molecular Endocrinology

Volumn 22, Issue 6, 2008, Pages 1403-1415

  Zhao, Liping ^a   Ki, Woo Kim ^a   Ikeda, Yayoi ^b   Anderson, Kimberly K ^a   Beck, Laurel ^c   Chase, Stephanie ^a,c   Tobet, Stuart A ^c   Parker, Keith L ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CRE RECOMBINASE; ESTRADIOL; PROTEIN; STEROIDOGENIC FACTOR 1; TESTOSTERONE; UCN 3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN MALFORMATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSFECTION; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; KNOCKOUT MOUSE; LOCOMOTION; LOXP SITE; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; STRESS; TISSUE DISTRIBUTION; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; ANXIETY; BEHAVIOR, ANIMAL; BINDING SITES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STEROIDOGENIC FACTOR 1;

MUS;

EID: 44649177751     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0034     Document Type: Article

References (37)

1. Parker KL, Rice DA, Lala DS, Ikeda Y, Luo X, Wong M, Bakke M, Zhao L, Frigeri C, Hanley NA, Stallings N, Schimmer BP 2002 Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res 57:19-36
2. Ikeda Y, Takeda Y, Shikayama T, Mukai T, Hisano S, Morohashi KI 2001 Comparative localization of Dax-1 and Ad4BP/SF-1 during development of the hypothalamic-pituitary-gonadal axis suggests their closely related and distinct functions. Dev Dyn 220:363-376
3. Canteras NS, Simerly RB, Swanson LW 1994 Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol 348:41-79
4. McClellan KM, Parker KL, Tobet S 2006 Development of the ventromedial nucleus of the hypothalamus. Front Neuroendocrinol 27:193-209
5. Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL 1995 The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 9:478-486
6. Shinoda K, Lei H, Yoshii H, Nomura M, Nagano M, Shiba H, Sasaki H, Osawa Y, Ninomiya Y, Niwa O, Morohashi K-i, Li E 1995 Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 204:22-29
7. Tran PV, Lee MB, Marin O, Xu B, Jones KR, Reichardt LF, Rubenstein JR, Ingraham HA 2003 Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci 22:441-453
8. Dellovade TL, Young M, Ross EP, Henderson R, Caron K, Parker K, Tobet SA 2000 Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J Comp Neurol 423:579-589
9. Davis AM, Seney ML, Stallings NR, Zhao L, Parker KL, Tobet SA 2004 Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamus. J Neurobiol 60:424-436
10. Majdic G, Young M, Gomez-Sanchez E, Anderson P, Szczepaniak LS, Dobbins RL, McGarry JD, Parker KL 2002 Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143:607-614
11. Zhao L, Bakke M, Krimkevich Y, Cushman LJ, Parlow AF, Camper SA, Parker KL 2001 Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. Development 128:147-154
12. Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490
13. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G 1999 Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103
14. Crawley JN 2001 What's wrong with my mouse? New York: Wiley Liss
15. Deacon RM 2006 Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc 1:122-124
16. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L 1999 Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:15239-15244
17. Kernie SG, Liebl DJ, Parada LF 2000 BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290-1300
18. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R 2001 Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15: 1748-1757
19. Sugiyama N, Kanba S, Arita J 2003 Temporal changes in the expression of brain-derived neurotrophic factor mRNA in the ventromedial nucleus of the hypothalamus of the developing rat brain. Brain Res 115:69-77
20. Roselli CE, Jorgensen EZ, Doyle MW, Ronnekleiv OK 1997 Expression of the orphan receptor steroidogenic factor-1 mRNA in the rat medial basal hypothalamus. Brain Res 44:66-72
21. Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J 2000 Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24:415-419
22. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF 2000 Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414
23. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP 2000 Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin- releasing hormone receptor-2. Nat Genet 24:403-409
24. Nishiyama M, Makino S, Asaba K, Hashimoto K 1999 Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat. J Neuroendocrinol 11:307-314
25. Ohata H, Suzuki K, Oki Y, Shibasaki T 2000 Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res 861:1-7
26. Valdez GR, Zorrilla EP, Rivier J, Vale WW, Koob GF 2003 Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res 980:206-212
27. Li C, Vaughan J, Sawchenko PE, Vale WW 2002 Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22:991-1001
28. Tran PV, Akana SF, Malkovska I, Dallman MF, Parada LF, Ingraham HA 2006 Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage. J Comp Neurol 498:637-648
29. Pieri I, Klein M, Bayertz C, Gerspach J, van der Ploeg A, Pfizenmaier K, Eisel U 1999 Regulation of the murine NMDA-receptor-subunit NR2C promoter by Sp1 and fushi tarazu factor1 (FTZ-F1) homologues. Eur J Neurosci 11:2083-2092
30. Segal JP, Stallings NR, Lee CE, Zhao L, Socci N, Viale A, Harris TM, Soares MB, Childs G, Elmquist JK, Parker KL, Friedman JM 2005 Use of laser-capture microdissection for the identification of marker genes for the ventromedial hypothalamic nucleus. J Neurosci 25:4181-4188
31. Kurrasch DM, Cheung CC, Lee FY, Tran PV, Hata K, Ingraham HA 2007 The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci 27:13624-13634
32. Forni PE, Scuoppo C, Imayoshi I, Taulli R, Dastru W, Sala V, Betz UA, Muzzi P, Martinuzzi D, Vercelli AE, Kageyama R, Ponzetto C 2006 High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. J Neurosci 26:9593-9602
33. Dielenberg RA, Hunt GE, McGregor IS 2001 "When a rat smells a cat": the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 104:1085-1097
34. Canteras NS 2002 The medial hypothalamic defensive system: hodological organization and functional implications. Pharm Biochem Behav 71:481-491
35. McGregor IS, Hargreaves GA, Apfelbach R, Hunt GE 2004 Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J Neurosci 24:4134-4144
36. Bingham NC, Verma-Kurvari S, Parada LF, Parker KL 2006 Development of a steroidogenic factor 1/Cre transgenic mouse line. Genesis 44:419-424
37. Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY, Park HJ, Shin HD, Park KS 2004 Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47:559-565